REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 392 filers reported holding REPLIGEN CORP in Q3 2020. The put-call ratio across all filers is 0.30 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $2,122,324 | +193.2% | 15,003 | +248.9% | 0.02% | +157.1% |
| Q1 2023 | $723,948 | -56.5% | 4,300 | -56.2% | 0.01% | -50.0% |
| Q4 2022 | $1,663,471 | -18.9% | 9,825 | -10.3% | 0.01% | -17.6% |
| Q3 2022 | $2,050,000 | +232.3% | 10,956 | +370.2% | 0.02% | +183.3% |
| Q4 2021 | $617,000 | -24.4% | 2,330 | -17.5% | 0.01% | -25.0% |
| Q3 2021 | $816,000 | +115.3% | 2,825 | +44.8% | 0.01% | +60.0% |
| Q1 2021 | $379,000 | -55.3% | 1,951 | -71.6% | 0.01% | -54.5% |
| Q2 2020 | $848,000 | +125.5% | 6,868 | +40.2% | 0.01% | 0.0% |
| Q3 2019 | $376,000 | -57.8% | 4,900 | -71.0% | 0.01% | -67.6% |
| Q4 2018 | $891,000 | -35.4% | 16,896 | -42.3% | 0.03% | -54.7% |
| Q2 2018 | $1,379,000 | -73.4% | 29,300 | -76.6% | 0.08% | -86.0% |
| Q2 2017 | $5,180,000 | +263.5% | 125,000 | +208.7% | 0.53% | +273.4% |
| Q1 2017 | $1,425,000 | +14.9% | 40,487 | +0.7% | 0.14% | -11.2% |
| Q4 2016 | $1,240,000 | – | 40,224 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 12 West Capital Management LP | 1,021,641 | $295,244,000 | 13.47% |
| Ally Bridge Group (NY) LLC | 70,000 | $20,229,000 | 5.95% |
| Miura Global Management | 85,000 | $24,564,000 | 3.81% |
| Conestoga Capital Advisors, LLC | 871,390 | $251,823,000 | 3.48% |
| Ranger Investment Management | 187,723 | $54,250,000 | 2.90% |
| AWM Investment Company, Inc. | 100,000 | $28,899,000 | 2.84% |
| Brown Capital Management | 1,017,477 | $294,041,000 | 2.41% |
| Stephens Investment Management Group LLC | 558,287 | $161,339,000 | 2.19% |
| Yorktown Management & Research Co Inc | 10,050 | $2,904,000 | 2.18% |
| SV Health Investors, LLC | 14,541 | $4,203,000 | 2.06% |